 Amneal Pharmaceuticals Inc NYSE: AMRX has agreed to acquire Saols Baclofen franchise, including Lioresal, Lyvispah, and a pipeline product under development for 83.5 million in cash. The acquisition expands Amneals commercial institutional and specialty portfolio in neurology while adding commercial infrastructure in advance of its entry into the biosimilar institutional market. 